Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated with HD
Phase 1
Terminated
- Conditions
- Huntington Disease
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Fundacion Huntington Puerto Rico
- Target Recruit Count
- 36
- Registration Number
- NCT04301726
- Locations
- 🇵🇷
Fundacion Huntington Puerto Rico, Inc. - Huntington's disease Clinic, San Juan, Puerto Rico
© Copyright 2025. All Rights Reserved by MedPath